Literature DB >> 17804010

Isolation, propagation and characterization of cord blood derived CD4+ CD25+ regulatory T cells.

Suzanne Bresatz1, Tim Sadlon, Debrah Millard, Heddy Zola, Simon C Barry.   

Abstract

Regulatory T cells (Treg) have recently come to the fore in studies of immune regulation, particularly in autoimmune disease and cancer. While there appear to be several distinct subsets of T cells with regulatory function, a population described as natural Treg and characterized by expression of the transcription factor FOXP3 has attracted particular interest. These cells can be enriched using the surface markers CD4 and CD25, and cord blood is a convenient source of CD25+ Treg. We present detailed protocols for the enrichment of Treg from cord blood using CD25 and a magnetic bead procedure, yielding populations >80% positive for CD25 and 50-65% FOXP3 positive. This enrichment can be followed by a second magnetic bead or a flow sorting step, yielding >95% CD25 and >65% FOXP3 positive populations. Protocols are presented for propagation of these cells in culture (yielding >80% FOXP3 positive cells) and for their phenotypic and functional characterization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17804010     DOI: 10.1016/j.jim.2007.06.006

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

Review 1.  Umbilical cord blood graft engineering: challenges and opportunities.

Authors:  P A Thompson; K Rezvani; C M Hosing; B Oran; A L Olson; U R Popat; A M Alousi; N D Shah; S Parmar; C Bollard; P Hanley; P Kebriaei; L Cooper; J Kellner; I K McNiece; E J Shpall
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

2.  Changes in chemokine receptor expression of regulatory T cells after ex vivo culture.

Authors:  Rikhia Chakraborty; Cliona Rooney; Gianpietro Dotti; Barbara Savoldo
Journal:  J Immunother       Date:  2012-05       Impact factor: 4.456

3.  3DFAACTS-SNP: using regulatory T cell-specific epigenomics data to uncover candidate mechanisms of type 1 diabetes (T1D) risk.

Authors:  Ning Liu; Timothy Sadlon; James Breen; Simon C Barry; Ying Y Wong; Stephen Pederson
Journal:  Epigenetics Chromatin       Date:  2022-06-30       Impact factor: 5.465

Review 4.  Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?

Authors:  Leigh R Guerin; Jelmer R Prins; Sarah A Robertson
Journal:  Hum Reprod Update       Date:  2009-03-11       Impact factor: 15.610

5.  Multiple unit pooled umbilical cord blood is a viable source of therapeutic regulatory T cells.

Authors:  Kate Milward; Fadi Issa; Joanna Hester; Daniel Figueroa-Tentori; Alejandro Madrigal; Kathryn J Wood
Journal:  Transplantation       Date:  2013-01-15       Impact factor: 4.939

6.  Chronically HIV-1 Infected Patients Exhibit Low Frequencies of CD25+ Regulatory T Cells.

Authors:  Cesar Mauricio Rueda Rios; Paula Andrea Velilla; Maria Teresa Rugeles
Journal:  Open Virol J       Date:  2012-04-11

7.  A microRNA profile of human CD8(+) regulatory T cells and characterization of the effects of microRNAs on Treg cell-associated genes.

Authors:  Fadi Jebbawi; Hussein Fayyad-Kazan; Makram Merimi; Philippe Lewalle; Jean-Christophe Verougstraete; Oberdan Leo; Pedro Romero; Arsene Burny; Bassam Badran; Philippe Martiat; Redouane Rouas
Journal:  J Transl Med       Date:  2014-08-06       Impact factor: 5.531

8.  FOXP3 and miR-155 cooperate to control the invasive potential of human breast cancer cells by down regulating ZEB2 independently of ZEB1.

Authors:  Cheryl Y Brown; Sonia Dayan; Soon Wei Wong; Adrian Kaczmarek; Christopher M Hope; Stephen M Pederson; Victoria Arnet; Gregory J Goodall; Darryl Russell; Timothy J Sadlon; Simon C Barry
Journal:  Oncotarget       Date:  2018-06-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.